Skip to content

The effect of faecal transplant on insulin sensitivity in adults with pre-diabetes and diet-controlled diabetes

The potential impact of faecal microbial transplant on insulin sensitivity in adults with pre-diabetes and diet-controlled diabetes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616001094460
Enrollment
10
Registered
2016-08-12
Start date
2016-10-01
Completion date
2017-09-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

There is growing evidence that gut microbiota is involved in the pathogenesis of type 2 diabetes mellitus. In humans, there is very little data on the effect of gut microbiota transfer on glucose metabolism. The objective of this study is to examine the feasibility of performing colonic faecal microbiota transplantation (FMT) in overweight pre-diabetic/diabetic adults and any potential metabolic effects of altering human colonic microbiota on insulin sensitivity.

Interventions

A group of overweight adults with pre-diabetes or diet-controlled diabetes will be randomised to receive a faecal microbial transplant (FMT) from either a lean healthy donor or their own gut microbiota. The donated faeces will be homogenised with 500 mL of normal saline in a blender and all of the 500 mL will be infused via colonoscopy into the colon of the recipient. The colonoscopy will take approximately 20 minutes and will be performed by a gastroenterologist. Measurements of weight, HbA1c,

A group of overweight adults with pre-diabetes or diet-controlled diabetes will be randomised to receive a faecal microbial transplant (FMT) from either a lean healthy donor or their own gut microbiota. The donated faeces will be homogenised with 500 mL of normal saline in a blender and all of the 500 mL will be infused via colonoscopy into the colon of the recipient. The colonoscopy will take approximately 20 minutes and will be performed by a gastroenterologist. Measurements of weight, HbA1c, fasting glucose and insulin, and oral glucose tolerance test will be performed at regular intervals post-FMT to determine effect of gut microbiota transfer on weight and glucose metabolism. No specific strategies to monitor adherence are required.

Sponsors

University of Auckland
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility criteria will be: Body mass index (BMI) of 25 kg/m2 or greater. Aged 18 years or above. Fasting blood glucose >6.0 mmol/L or HbA1c >40 mmol/mol Not taking any glucose lowering medications

Exclusion criteria

Anyone lacking mental capacity to provide informed consent. Prebiotic/probiotic supplements or antibiotics in the last 3 months. Past cholecystectomy.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026